Shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) have earned an average recommendation of “Hold” from the ten research firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $34.89.
Several research firms recently weighed in on OHI. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Wells Fargo & Company upgraded Omega Healthcare Investors to a “strong-buy” rating in a research report on Friday, June 14th. Scotiabank upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Finally, Truist Financial boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th.
Get Our Latest Analysis on OHI
Hedge Funds Weigh In On Omega Healthcare Investors
Omega Healthcare Investors Price Performance
Shares of NYSE OHI opened at $40.46 on Friday. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. Omega Healthcare Investors has a one year low of $27.53 and a one year high of $41.53. The firm has a market capitalization of $10.00 billion, a P/E ratio of 36.45, a PEG ratio of 1.32 and a beta of 1.00. The company’s fifty day moving average is $38.54 and its two-hundred day moving average is $34.18.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company had revenue of $252.70 million for the quarter, compared to analysts’ expectations of $205.92 million. During the same period in the prior year, the firm posted $0.74 EPS. The firm’s quarterly revenue was up 17.5% on a year-over-year basis. Analysts forecast that Omega Healthcare Investors will post 2.69 EPS for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a yield of 6.62%. Omega Healthcare Investors’s payout ratio is 241.44%.
About Omega Healthcare Investors
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Read More
- Five stocks we like better than Omega Healthcare Investors
- Options Trading – Understanding Strike Price
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- NYSE Stocks Give Investors a Variety of Quality Options
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- When to Sell a Stock for Profit or Loss
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.